| 6.27 Delayed Data As of Sep 13 |  -0.03 / -0.48%Today’s Change | 1.38 Today|||52-Week Range 19.40 | +264.53% Year-to-Date |
| Previous close | 6.30 |
| Today’s open | 6.31 |
| Day’s range | 6.19 - 6.50 |
| Volume | 47,614 |
| Average volume (3 months) | 81,276 |
| Market cap | $32.5M |
| Earnings growth (last year) | +10.91% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 17.18 |
| Today’s change | Today’s % change | |
|---|---|---|
| HSGXHistogenics Corp | +0.02 | +7.56% |
| BCDABioCardia Inc | -0.02 | -0.41% |
| CLBSCaladrius Bioscience... | 0.00 | 0.00% |
| SNGXSoligenix Inc | -0.02 | -2.21% |
| Next reporting date | November 1, 2019 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$7.2M |
| Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Harel Gadot |
Chief Financial Officer David Ben Naim |
Corporate headquarters Hingham, Massachusetts |
